Nuvalent, Inc. (NUVL)
$123.96+0.00%Close
BUYBULL · day 29
Key stats
- Market cap
- $9.1B
- Beta
- 1.14
- P/E (TTM)
- -20.46
- 1W
- +0.00%
- 1M
- +0.43%
- vs SPY 1W
- -0.42%
- vs SPY 1M
- -1.63%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on NUVL?
- LOPJLB’s latest quantitative signal on Nuvalent, Inc. (NUVL) is BUY in a BULL regime. Signals are updated daily.
- What market regime is NUVL in?
- Nuvalent, Inc. (NUVL) is currently classified in the BULL HMM market regime on LOPJLB.
- What does Nuvalent, Inc. (NUVL) do?
- Nuvalent, Inc. is a clinical-stage biopharmaceutical firm dedicated to pioneering novel therapeutic solutions for individuals battling cancer. The company's pipeline features two prominent drug candidates. One of these is NVL-520, a highly selective ROS1 inhibitor capable of penetrating the brain. This compound is specifically designed to target ROS1 fusions that possess the normal ROS1 kinase …